Marco Lucci Chiarissi
Papers
1
Total Citations
252
H-Index
1
About
Marco Lucci Chiarissi is a pioneering urological surgeon whose research has fundamentally shaped the landscape of minimally invasive prostate cancer surgery. His landmark 2012 randomised controlled trial, which directly compared laparoscopic and robot-assisted radical prostatectomy, remains a cornerstone of the field with over 250 citations. This seminal work provided critical, evidence-based insights into the comparative outcomes of these two advanced surgical techniques, helping to guide clinical decision-making worldwide. Beyond this defining study, Chiarissi’s research portfolio focuses on refining surgical precision, reducing postoperative complications, and improving oncological and functional outcomes for patients. His contributions have been instrumental in demonstrating the safety and efficacy of robotic surgery, driving its widespread adoption. Through rigorous clinical trials and a commitment to patient-centered research, Chiarissi has established himself as a leading authority in urologic oncology, influencing both surgical practice and the training of the next generation of surgeons.
Research Focus
Key Achievements
Top Papers
- 1